Finding effective treatments for SARS-CoV-2 means identifying key pathways to target, which is made all the more difficult when facing a completely new disease. Researchers in the Korcsmaros Group at EI are therefore applying their expertise in systems biology to tackle the problem from a holistic perspective.
Click here for original story, ViralLink identifies key proteins in SARS-CoV-2-infected cells: workflow open to all
Source: Phys.org